Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma-Cell Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06171685
What this trial is testing

MMRC Horizon One: RRMM (MMRC-099)

Who this might be right for
Relapse Multiple MyelomaRefractory Multiple Myeloma
Multiple Myeloma Research Consortium 300
Testing effectiveness (Phase 2)WithdrawnNCT01332617
What this trial is testing

Phase II Study of Simvastatin for Relapsed/Refractory Myeloma

Who this might be right for
Myeloma
University of Louisville
Testing effectiveness (Phase 2)Active Not RecruitingNCT06169215
What this trial is testing

Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 58
Early research (Phase 1)Study completedNCT02616640
What this trial is testing

Determine Dose and Regimen of Durvalumab as Monotherapy or in Combination With Pomalidomide With or Without Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 114
Early research (Phase 1)Study completedNCT06203912
What this trial is testing

Donor Immune Cells (TGFbi NK Cells) and Isatuximab for the Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
Elvira Umyarova 3
Not applicableUnknownNCT05088330
What this trial is testing

Access of Daratumumab Combined With VRD in the Treatment of Patients With Standard-risk Newly Diagnosed MM

Who this might be right for
Newly Diagnosed Multiple Myeloma
The First Affiliated Hospital of Soochow University 76
Not applicableStudy completedNCT00440765
What this trial is testing

VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands

Who this might be right for
Multiple MyelomaHematological Neoplasms
Janssen-Cilag B.V. 331
Not applicableStudy completedNCT03188536
What this trial is testing

Clinical and Sociodemographic Characterization of Multiple Myeloma Participants With Symptomatic Relapse and/or Refractory Disease in Spain (CharisMMa Study)

Who this might be right for
Multiple Myeloma
Takeda 282
Testing effectiveness (Phase 2)Looking for participantsNCT07489534
What this trial is testing

Study of PD-1Ab21-BCMA CAR-T Therapy for Consolidation of Multiple Myelomawith Renal Dysfunction

Who this might be right for
Multiple Myeloma
Daihong Liu 25
Large-scale testing (Phase 3)Active Not RecruitingNCT06413498
What this trial is testing

A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Kite, A Gilead Company 452
Testing effectiveness (Phase 2)Study completedNCT01866293
What this trial is testing

Cabozantinib (XL184) in Patients With Relapsed or Refractory Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Memorial Sloan Kettering Cancer Center 11
Not applicableStudy completedNCT01171430
What this trial is testing

"WB-DCE-MRI" in Multiple Myeloma as an Independent Prognostic Factor for Disease-free Survival

Who this might be right for
Multiple Myeloma
Assistance Publique - Hôpitaux de Paris 104
Testing effectiveness (Phase 2)Study completedNCT01054144
What this trial is testing

Study of Single Agent Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 27
Testing effectiveness (Phase 2)Study completedNCT01782963
What this trial is testing

Lenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Massachusetts General Hospital 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT02542657
What this trial is testing

Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple Myeloma

Who this might be right for
Myeloma
Joseph Tuscano 30
Not applicableLooking for participantsNCT07665307
What this trial is testing

Delayed Toxicities Post-CAR-T

Who this might be right for
Multiple Myeloma
Icahn School of Medicine at Mount Sinai 30
Not applicableStudy completedNCT04629430
What this trial is testing

Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT

Who this might be right for
Multiple MyelomaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+9 more
University of Virginia 40
Not applicableStudy completedNCT02033928
What this trial is testing

Comprehensive Frailty Assessment

Who this might be right for
Myeloma, MultipleParaproteinemiasHematologic Neoplasms
Ohio State University Comprehensive Cancer Center 111
Testing effectiveness (Phase 2)WithdrawnNCT01652014
What this trial is testing

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more
University of Medicine and Dentistry of New Jersey
Not applicableStudy completedNCT00301275
What this trial is testing

Assessing Free Immunoglobulin Light Chains in Patients With Myeloma

Who this might be right for
Multiple Myeloma
Royal Marsden NHS Foundation Trust
Next Page